QNRXNasdaqPharmaceutical Preparations
Quoin Pharmaceuticals Ltd.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$3.98+0.08 (+2.05%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
64.7%
1M of 2M shares
Institutional holders
19
1 new, 3 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
4 buys · 0 sales
Net bought $279.97K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Stonepine GP, LLC | 7,594,166 | 9.99% | 13G (passive) amendment | Mar 31, 2026 |
| Aberdeen Group plc | 75,000 | 8.94% | 13G (passive) | Dec 31, 2025 |
| Daniel Schneeberger | 58,230 | 6.90% | 13G (passive) | Dec 31, 2025 |
| Resolute Capital Asset Partners LLC | 50,000 | 8.50% | 13G (passive) | Oct 10, 2025 |
| Integrated Core Strategies (US) LLC | 3,850,385 | 5.50% | 13G (passive) | May 26, 2026 |
| Stonepine Capital Management, LLC | 3,030,926 | 9.90% | 13G (passive) | Dec 10, 2025 |
| Neil Shahrestani | 211,538 | 12.60% | 13G (passive) amendment | Jan 31, 2026 |
| Millennium Group Management LLC | 1,901,585 | 9.00% | 13G (passive) | Oct 20, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of QNRX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Dauntless Investment Group, LLC | 214,987 | 10.70% | $1.04M | +18,395 | 0.82% |
| Ikarian Capital, LLC | 211,538 | 10.53% | $1.02M | – | 0.11% |
| Stonepine Capital Management, LLC | 199,486 | 9.93% | $965.51K | +146,026 | 0.54% |
| Millennium Management LLC | 112,323 | 5.59% | $543.64K | +36,076 | 0.00% |
| SummitTX Capital, L.P. | 100,300 | 4.99% | $485.45K | – | 0.01% |
| Woodline Partners LP | 76,446 | 3.81% | $370.00K | −3,136 | 0.00% |
| abrdn plc | 75,000 | 3.73% | $363.00K | – | 0.00% |
| Soleus Capital Management, L.P. | 72,730 | 3.62% | $352.01K | – | 0.01% |
| AIGH Capital Management LLC | 70,000 | 3.49% | $338.80K | +19,000 | 0.02% |
| Boothbay Fund Management, LLC | 59,838 | 2.98% | $289.62K | – | 0.00% |
| Velan Capital Investment Management LP | 32,372 | 1.61% | $156.68K | −52,477 | 0.10% |
| Barclays PLC | 21,469 | 1.07% | $103.91K | +20,169 | 0.00% |
| Birchview Capital, LP | 20,000 | 1.00% | $96.80K | – | 0.05% |
| XTX Topco Ltd | 15,006 | 0.75% | $72.63K | New | 0.00% |
| Morgan Stanley | 8,000 | 0.40% | $38.72K | +4,000 | 0.00% |
| UBS Group AG | 6,772 | 0.34% | $32.78K | +4,260 | 0.00% |
| Rhumbline Advisers | 2,332 | 0.12% | $11.28K | +811 | 0.00% |
| GAMMA Investing LLC | 439 | 0.02% | $2.13K | −1,281 | 0.00% |
| SBI Securities Co., Ltd. | 355 | 0.02% | $1.72K | +353 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 19 | 1M | 64.7% | 1 / 9 | 3 / 3 | 0M | 0M |
| Q1 2026 | 21 | 1M | 59.0% | 6 / 7 | 4 / 3 | 0M | 0M |
| Q4 2025 | 18 | 1M | 42.0% | 14 / 4 | 0 / 0 | 1M | 0M |
| Q3 2025 | 4 | 0M | 0.1% | 0 / 1 | 2 / 2 | 0M | 0M |
| Q2 2025 | 6 | 0M | 0.1% | 5 / 0 | 1 / 0 | 0M | 0M |
| Q1 2025 | 1 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Michael Myers | Chief Executive Officer, Director | 37,713 | 1.88% | Sep 1, 2026 |
| Denise P. Carter | Chief Operating Officer, Director | 37,709 | 1.88% | Sep 1, 2026 |
| Sally Bridget Lawlor | Chief Financial Officer | 10,684 | 0.53% | Sep 1, 2026 |
| Gordon Dunn | Chief Financial Officer | 151,077 | 7.52% | Dec 27, 2024 |
| Anthony James Culverwell | Director | 40,364 | 2.01% | Sep 1, 2026 |
| Dennis Langer | Director | 56,243 | 2.80% | Aug 28, 2026 |
| Michael T. Sember | Director | – | – | Feb 6, 2026 |
| Joseph Patrick Cooper | Director | – | – | Feb 6, 2026 |
| Natalie Ee Mun Leong | Director | – | – | Feb 6, 2026 |
| Stonepine Capital Management, LLC | 10% owner | 3,271,100 | 162.87% | Mar 31, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Denise P. Carter Chief Operating Officer, Director | Aug 31, 2026 | Buy | +20,490 | $4.88 | $99.99K | 37,709 |
| Sally Bridget Lawlor Chief Financial Officer | Aug 31, 2026 | Buy | +10,244 | $4.88 | $49.99K | 10,684 |
| Michael Myers Chief Executive Officer, Director | Aug 31, 2026 | Buy | +20,490 | $4.88 | $99.99K | 37,713 |
| Anthony James Culverwell Director | Aug 31, 2026 | Buy | +6,146 | $4.88 | $29.99K | 40,364 |
| Anthony James Culverwell Director | Aug 27, 2026 | Award | +31,352 | $5.15 | $161.46K | 34,218 |
| Dennis Langer Director | Aug 27, 2026 | Award | +34,534 | $5.15 | $177.85K | 56,243 |
| Dennis Langer Director | Oct 14, 2025 | Buy | +15,152 | $8.49 | $128.64K | 15,153 |
| Anthony James Culverwell Director | Dec 23, 2024 | Buy | +100,000 | $0.45 | $45.00K | 100,317 |
| Gordon Dunn Chief Financial Officer | Dec 23, 2024 | Buy | +122,221 | $0.45 | $55.00K | 151,077 |
| Denise P. Carter Chief Operating Officer, Director | Dec 23, 2024 | Buy | +555,556 | $0.45 | $250.00K | 602,648 |
| Michael Myers Chief Executive Officer, Director | Dec 23, 2024 | Buy | +555,556 | $0.45 | $250.00K | 602,808 |
| Gordon Dunn Chief Financial Officer | Sep 10, 2024 | Buy | +10,000 | $0.71 | $7.10K | 28,856 |
| Gordon Dunn Chief Financial Officer | Sep 10, 2024 | Buy | +10,000 | $0.91 | $9.10K | 18,856 |
| Gordon Dunn Chief Financial Officer | Sep 9, 2024 | Buy | +856 | $0.80 | $685 | 856 |
| Gordon Dunn Chief Financial Officer | Sep 9, 2024 | Buy | +4,000 | $0.78 | $3.12K | 4,856 |
| Gordon Dunn Chief Financial Officer | Sep 9, 2024 | Buy | +4,000 | $0.80 | $3.20K | 8,856 |
| Michael Myers Chief Executive Officer, Director | Sep 4, 2024 | Buy | +8,200 | $0.75 | $6.15K | 23,680 |
| Michael Myers Chief Executive Officer, Director | Sep 4, 2024 | Buy | +23,572 | $0.80 | $18.86K | 47,252 |
| Michael Myers Chief Executive Officer, Director | Sep 4, 2024 | Buy | +5,322 | $0.66 | $3.51K | 15,480 |
| Denise P. Carter Chief Operating Officer, Director | Sep 4, 2024 | Buy | +22,988 | $0.80 | $18.39K | 47,092 |
| Denise P. Carter Chief Operating Officer, Director | Sep 4, 2024 | Buy | +8,825 | $0.75 | $6.62K | 24,104 |
| Michael Myers Chief Executive Officer, Director | Sep 3, 2024 | Buy | +800 | $0.62 | $496 | 10,158 |
| Denise P. Carter Chief Operating Officer, Director | Sep 3, 2024 | Buy | +1,822 | $0.63 | $1.15K | 11,179 |
| Denise P. Carter Chief Operating Officer, Director | Sep 3, 2024 | Buy | +4,100 | $0.66 | $2.71K | 15,279 |
| Dennis Langer Director | Jun 7, 2024 | Sale | −297 | $0.73 | $217 | 53 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Dennis Langer Director | Jun 7, 2024 | 297 | $218 | Jun 7, 2024 | Pre IPO Offering |